🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Our latest paper showing that The Cardioprotective Effects of Semaglutide Exceed Those of Dietary We... sciencedirect.com/science/articl… Laura Meems Novo Nordisk UMCG Cardiology Research Institute UMCG Erasmus MC Mikhail Kosiborod Christoph Maack Johann Bauersachs

#1 🐭💓 A new preclinical study from our institute ! Aad Withaar and Laura Meems explored semaglutide in the context of #HFpEF Rudolf de Boer #MondayScientificSnack

Q: What is the penetrance & prognosis of MYH7 variant-associated cardiomyopathies? A: Early penetrance & major cardiomyopathy-related events were common among NCCM variant & DCM variant carriers of MYH7. More in #JACCHF: bit.ly/3QvcYGY

Hot of the press‼️ Focus issue of #EHJ #HeartFailure and #Cardiomyopathies ✅ Several #LBT from #HFA Congress. ➡️ more to come at #ESCCongress next week in Amsterdam‼️ EHJ Editor-in-Chief European Society of Cardiology Journals Shelley Zieroth Rudolf de Boer Wilfried Mullens HFAPresident Javed Butler Robert Mentz, MD

Let’s begin! #ESC2023 #Amsterdam European Society of Cardiology

Big news #ESC2023 and NEJM In a placebo-controlled randomized trial of people with obesity + heart failure (with preserved ejection fraction). semaglutide (Wegovy) markedly improved symptoms, exercise time, reduced inflammatory markers (and weight loss) nejm.org/doi/full/10.10…

⚠️#RED-CVD: Improving early diagnosis of CV disease in patients with DM2 & COPD 👉 The diagnostic strategy more than doubled the number of new diagnoses of heart failure, atrial fibrillation andcoronary artery disease #ESCcongress European Society of Cardiology

This work by Drs. Withaar, Rudolf de Boer, et al, shows that GLP-1 receptor agonist semaglutide may be a promising & effective therapeutic option for #HFpEF, & affords additional effects over food restriction. bit.ly/3G1yv3L #Obesity #Heartfailure #JACCBTS Laura Meems

🔥 hot of the press in #EJHF‼️ ➡️ Design of HF-REVERT investigating the microRNA inhibitor CDR132L in patients with acute MI and LV dysfunction. Thomas Thum Claudia Ulbrich Rudolf de Boer Javed Butler scottdavidsolomon Mark Petrie Tienush Rassaf David Duncker

Heart failure-induced microbial dysbiosis contributes to colonic tumour formation in mice. We provide a new layer of evidence - the microbiome - between prevalent heart failure and incident cancer. Joseph Pierre Aboumsallèm Wouter Meijers International Cardio-Oncology Society European Society of Cardiology Journals academic.oup.com/cardiovascres/…

Honored, humbled and very excited to be selected as candidate for position of president-elect for the #HFA board elections! To all members, please don’t forget to vote for these fantastic people! escardio.org/Sub-specialty-… Here are my top six priorities....together we can make it

Congratulations to HFA! So many great memories! Looking forward to the next 20 years! HFAPresident Alexandre Mebazaa @PCSchulzeMD Johann Bauersachs Johannes Backs Christoph Maack Gabriele G. Schiattarella Tiny Jaarsma

The congress has started! #20yearsHFA